Hussein Mecklai
On May 22, 2025, Impinj, Inc. (the “Company”) announced that Hussein Mecklai has resigned from the position of Chief Operating Officer of the Company, effective May 20, 2025.
Highest-materiality recent filing
Revenue $74.3M, exceeding top of guidance; gross margin 49.1% GAAP / 52.4% non-GAAP.
Impinj Q4 2025 revenue $92.8M; non-GAAP EPS $0.50, record adjusted EBITDA $16.4M
Q4 revenue $92.8M; full year revenue $361.1M.
Impinj preannounces Q4 2025 revenue near high end of guidance, adjusted EBITDA above midpoint
Q4 2025 revenue expected near high end of prior guidance of $90–93 million.
Impinj Q3 2025: Revenue $96.1M, adj. EBITDA $19.1M; GAAP loss $0.44, non-GAAP EPS $0.58
Revenue $96.1M; GAAP gross margin 50.3%, non-GAAP gross margin 53.0%.
Impinj issues $190M 0% convert due 2029, repurchases 2027 notes with cash and stock
Priced $190M 0% Convertible Senior Notes due 2029; initial conversion price $267.39/share (37.5% premium).
Impinj proposes $150M convertible notes offering (up to $175M) for 2027 note exchange
Proposed offering of $150M aggregate principal amount of Convertible Senior Notes due 2029, with option for additional $25M.
Impinj Q2 2025 revenue $97.9M, GAAP EPS $0.39, non-GAAP EPS $0.80, beats guidance
Revenue of $97.9M; GAAP gross margin 57.8%, non-GAAP gross margin 60.4%.
Impinj COO Hussein Mecklai resigns effective May 20, 2025
Hussein Mecklai resigned as Chief Operating Officer, effective May 20, 2025.
Impinj Q1 revenue $74.3M beats guidance; non-GAAP EPS $0.21
GAAP net loss $8.5M ($0.30 loss per diluted share) vs. prior year loss.
Impinj Q3 revenue $95.2M, GAAP EPS $0.01, non-GAAP EPS $0.56, above guidance
Revenue $95.2M; GAAP net income $0.2M ($0.01 diluted EPS) on 29.7M shares.
Impinj posts record Q2 revenue $102.5M; adjusted EBITDA $26.8M beats guidance
GAAP net income $10.0M ($0.34 diluted EPS on 29.4M shares); non-GAAP net income $25.3M ($0.83 diluted EPS on 32.0M shares).
Impinj Q1 2024 revenue $76.8M beats guidance; GAAP EPS $1.10, non-GAAP EPS $0.21
Revenue $76.8M; GAAP gross margin 48.9%; non-GAAP gross margin 51.5%.
Impinj settles patent litigation with NXP; receives $45M upfront and annual license fees
One-time payment of $45M due within five business days of March 13, 2024.
Impinj Q4 revenue $70.7M, GAAP loss $0.56 EPS; cuts 10% staff
Q4 revenue $70.7M; full year $307.5M (first above $300M).
Impinj pre-announces Q4 2023 revenue >$70M, adjusted EBITDA >$2.5M
Q4 2023 revenue expected to exceed $70M, above prior guidance of $65.5-$68.5M.
Impinj Q3 revenue $65M; GAAP loss $0.59/share; non-GAAP EPS $0.00; Q4 outlook cautious
Revenue $65.0M; GAAP net loss $15.8M ($0.59 per diluted share on 26.9M shares).
Impinj Q2 2023 revenue $86M (record); GAAP EPS -$0.30, non-GAAP EPS $0.33; expects Q3 headwinds
Revenue of $86.0M, a record; GAAP net loss of $8.1M (-$0.30/diluted share); non-GAAP net income of $9.3M ($0.33/diluted share).
Impinj reports record Q1 revenue $85.9M; GAAP net loss $4.4M, non-GAAP net income $0.30 EPS
Record revenue $85.9M; GAAP gross margin 50.7%, non-GAAP 52.4%.
Impinj reports Q4 revenue $76.6M, non-GAAP EPS $0.41, full-year record $257.8M
Q4 revenue $76.6M, GAAP gross margin 52.4%, GAAP net loss ~$0.1M (<$0.01 per diluted share).
Impinj prelim Q4 2022 revenue above $76M, topping prior $71.5-73.5M guidance
Expected Q4 2022 revenue >$76M, surpasses prior guidance of $71.5-73.5M.
Impinj Q3 revenue $68.3M; non-GAAP EPS $0.34; record endpoint and reader IC sales
Revenue $68.3M; GAAP net loss $(0.09)/diluted share; non-GAAP net income $0.34/diluted share.
Impinj Q2 2022 revenue $59.8M, GAAP net loss $0.45/share, non-GAAP EPS $0.11, both beat guidance
Revenue of $59.8M; GAAP gross margin 52.7%; non-GAAP gross margin 54.7%.
Impinj repurchases all remaining 2026 convertible notes for ~$17.6M
Repurchased $9.85M aggregate principal of its 2.0% convertible senior notes due 2026.
Impinj Q1 record revenue $53.1M; GAAP loss $(0.42), non-GAAP profit $0.09
Revenue $53.1M (record); GAAP gross margin 54.2%, non-GAAP 57.0%.
Impinj Q4 revenue $52.6M, GAAP EPS -$0.81; FY21 revenue $190.3M, GAAP EPS -$2.12
Q4 2021 revenue of $52.6M, non-GAAP gross margin 58.2%; GAAP net loss $20.0M ($0.81/share).
Impinj appoints Meera Rao to board, promotes Hussein Mecklai as COO, chair transition
Board size set to nine; Meera Rao appointed director effective Feb 1, 2022.
Impinj expects Q4 2021 revenue above $52M, exceeding prior guidance of $46-48M
Preliminary Q4 2021 revenue exceeds $52M, above prior guidance of $46.0-48.0M.
Impinj prices $250M convertible notes at 1.125%, uses proceeds to repurchase existing 2026 notes
$250M principal of 1.125% Convertible Senior Notes due 2027, upsized from $225M; initial conversion price ~$111.04/share (42.5% premium).
Impinj Q3 revenue $45.2M beats guidance; non-GAAP EPS loss $0.04
Revenue of $45.2M exceeded guidance; GAAP gross margin 50.9%, non-GAAP 53.3%.
Impinj beats Q2 guidance with record bookings and adjusted EBITDA; revenue $47.3M
Revenue $47.3M, exceeding guidance; GAAP net loss $8.9M ($0.37 loss per share).
On May 22, 2025, Impinj, Inc. (the “Company”) announced that Hussein Mecklai has resigned from the position of Chief Operating Officer of the Company, effective May 20, 2025.
On February 5, 2025, the Company and Jeff Dossett, the Company’s Chief Revenue Officer, announced that Mr. Dossett intends to retire and will depart the Company effective February 21, 2025.
On April 24, 2023, Gregory Sessler, a member of the Company’s board of directors (the “Board”), notified the Board of his decision not to stand for re-election at the Company’s 2023 annual meeting of stockholders (the “2023 Annual Meeting”), when his current term as a director will expire.
appointed Miron L. Washington to serve as a director, with an initial term expiring at the Company’s next annual meeting of stockholders, in each case effective as of April 2, 2023.
appointed Meera Rao to serve as a director
the Board appointed Hussein Mecklai as the Company’s Chief Operating Officer, effective February 6, 2022.
director Steve Sanghi will assume the role of Board Chair following the end of Mr. van Oppen’s term.
each of Theresa Wise and Peter van Oppen, the Company’s Board Chair, notified the Board that they each decided to decline to stand for re-election at the Company’s 2022 Annual Meeting
each of Theresa Wise and Peter van Oppen, the Company’s Board Chair, notified the Board that they each decided to decline to stand for re-election at the Company’s 2022 Annual Meeting
Max materiality 0.75 · Median 0.65 · Most common event earnings